Dehydrated Amnion Patches

Amnio-Maxx

Dual Layer Amnion Allograft

Amnio-Maxx Dual Layer Amnion Patches are advanced wound care membranes made from human amniotic membrane. The amnion provides a natural scaffold that supports tissue regeneration and healing, and the dual-layer design protects the wound and may promote faster recovery and reduce inflammation.

These patches are typically used for chronic wounds, burns and surgical applications because they offer a natural source of growth factors, anti-inflammatory properties and other biological components that may assist in wound healing and support best possible outcomes.

Nonimmunogenic
Creates an environment which promotes antibacterial healing
Tissue regeneration/remodeling
Anti-inflammatory
Anti-adhesive/anti-scarring

Dual Layer

Two layers of amniotic tissue provides 2x the growth factor.

Easy to Use

Thicker graft facilitates handling in robotic and laparoscopic surgical procedures.

Surgical Barrier

Designed for scar tissue and inflammation reduction potential. (1)

Easy Placement

Dual layer allows placement of the graft on either side, eliminating orientation restrictions in surgical repair.

Chorion Free

Immune privileged, reducing the risk of adverse responses.

Biomechanical Integrity

Offers greater tensile strength, shape manipulation and slower resorption in vivo. (2)

Platelet Derived Growth Factor (PDGF) A & B
Transforming Growth Factor beta (TGFβ)
Epidermal Growth Factor (EGF)
Collagen Types I, III, IV, V, VII
Fibronectin
Hyaluronic Acid (HA)
Vascular Endothelial Growth Factor (VEGF)
Fibroblast Growth Factor (FGF)
Tissue Inhibitors of Metalloproteinases (TIMPs)
Laminin
Proteoglycans

Potential Benefits of Amniotic Membrane Growth Factors

The placenta contains growth factors and proteins that stimulate the body's own healing mechanism, reducing pain, inflammation and scar tissue. (3, 4, *)

1. Sinno, Prakash. Plast Surg Int. 2013:146764.

2. Spoerl, et al. Ophthalmic Res. 2004;36(2):71–7.

3. Martin, et al. Encyclopedia of Reproduction, 2018;3:387–398.

4. Mamede, et al. Cell Tissue Res. 2012, 349:447–458.

* Based on published studies; not specific to PalinGen Amniotic Membranes.